RxDoctor Payments Data

Sarah Peters

Physician Assistant · Danville, ILNPI 1770913709

Payments from drug & device makers

$2,503in general payments, 2019–2025

Across 23 payments — averaging $108.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$709
  • Amgen$145
  • Abiomed$71
  • Pfizer$40
  • Microtransponder, Inc.$18
  • plus $17 from 1 others

What the payments were for

  • Travel & lodging$1,22849%
  • Food & beverage$1,27551%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic14$1,501
Boston Scientific4$709
Amgen1$145
Abiomed1$71
Pfizer1$40
Microtransponder, Inc.1$18
Novo Nordisk1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,503 in reported general payments places this provider in the 85th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$30,387
Medicare patients
199
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban202$185,931
EntrestoSacubitril/Valsartan101$101,411
XareltoRivaroxaban62$50,014
Repatha SureclickEvolocumab50$44,887
JardianceEmpagliflozin45$39,219
Praluent PenAlirocumab17$8,389
Atorvastatin Calcium335$5,945
Metoprolol Succinate271$4,726
Ezetimibe111$4,001
Isosorbide Mononitrate ErIsosorbide Mononitrate169$3,804
Potassium Chloride119$3,369
CorlanorIvabradine Hcl11$3,255
Carvedilol167$2,909
Losartan Potassium170$2,481
Amlodipine Besylate197$2,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$40$185,931202 claims
AmgenCorlanor$145$3,25511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Danville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →